{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:17:20Z","timestamp":1785248240030,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Office of Research, Innovation and Development (ORID), University of Ghana","award":["URF\/6\/ILG-002\/2012-2013"],"award-info":[{"award-number":["URF\/6\/ILG-002\/2012-2013"]}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/J014532\/1"],"award-info":[{"award-number":["BB\/J014532\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Ghana-Carnegie Next Generation of Academics in Africa Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12906-017-1901-2","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T10:04:35Z","timestamp":1502100275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-6870","authenticated-orcid":false,"given":"Patrick","family":"Amoateng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Osei-safo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy K. E.","family":"Kukuia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia Oppong","family":"Bekoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Kombian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"key":"1901_CR1","first-page":"1","volume":"7","author":"T Ehmann","year":"2004","unstructured":"Ehmann T, Yager J, Hanson L. Early psychosis: a review of the treatment literature. Children\u2019s Mental Health Policy Research Program. 2004;7:1\u201352.","journal-title":"Children\u2019s Mental Health Policy Research Program"},{"key":"1901_CR2","doi-asserted-by":"crossref","unstructured":"Nuevo R, Chatterji S, Verdes E, Naidoo N, Arango C, Ayuso-Mateos JL. The Continuum of Psychotic Symptoms in the General Population: A Cross- national Study. Schizophrenia Bull. 2010;38:475-85.","DOI":"10.1093\/schbul\/sbq099"},{"key":"1901_CR3","first-page":"7","volume":"1","author":"V Sharifi","year":"2015","unstructured":"Sharifi V, Eaton WW, Wu LT, Roth KB, Burchett BM, Mojtabai R. Psychotic experiences and risk of death in the general population: 24\u201327 year follow-up of the Epidemiologic Catchment Area study. Br J Psych. 2015;1:7.","journal-title":"Br J Psych"},{"key":"1901_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","volume":"122","author":"P Harrison","year":"1999","unstructured":"Harrison P. The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain. 1999;122:593\u2013624.","journal-title":"Brain"},{"key":"1901_CR5","first-page":"239","volume":"12","author":"PE Mullen","year":"2006","unstructured":"Mullen PE. Schizophrenia and violence: from correlations to preventive strategies. Advances in PsychiatricTreatment. 2006;12:239\u201348.","journal-title":"Advances in PsychiatricTreatment"},{"key":"1901_CR6","volume-title":"Discoveries in Biological Psychiatric, vol","author":"FJ Ayd","year":"1970","unstructured":"Ayd FJ, Blackwell B. Discoveries in Biological Psychiatric, vol. Philadelphia: J. B. Lippincott Co.; 1970."},{"key":"1901_CR7","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1056\/NEJMc090291","volume":"360","author":"RJ Baldessarini","year":"2009","unstructured":"Baldessarini RJ. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:2136\u20137. author reply 2137-2138","journal-title":"N Engl J Med"},{"key":"1901_CR8","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 1991;148:1474.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 8","key":"1901_CR9","first-page":"5","volume":"61","author":"GW Arana","year":"2000","unstructured":"Arana GW. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry. 2000;61(Suppl 8):5\u201311. discussion 12-13","journal-title":"J Clin Psychiatry"},{"key":"1901_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225\u201335.","journal-title":"N Engl J Med"},{"key":"1901_CR11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.lfs.2004.04.014","volume":"75","author":"ZJ Zhang","year":"2004","unstructured":"Zhang ZJ. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci. 2004;75:1659\u201399.","journal-title":"Life Sci"},{"key":"1901_CR12","volume-title":"Traditional Medicine and Pharmacopoeia. Contribution to the revision of ethnobotanical and floristic studies in Ghana. Scientific, Technical and Research Commission of the Organization of African Unity: Scientific, Technical and Research Commission (OAU)","author":"NR Mshana","year":"2000","unstructured":"Mshana NR, Abbiw DK, Addae-Mensah I, Adjanohoun E, Ahyi MRA, Enow-Orock EG, Gbile ZO, Noamesi BK, Odei MA, Adunlami H et al. Traditional Medicine and Pharmacopoeia. Contribution to the revision of ethnobotanical and floristic studies in Ghana. Scientific, Technical and Research Commission of the Organization of African Unity: Scientific, Technical and Research Commission (OAU); 2000."},{"key":"1901_CR13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0975-7406.94816","volume":"4","author":"P Amoateng","year":"2012","unstructured":"Amoateng P, Woode E, Kombian SB. Anticonvulsant and related neuropharmacological effects of the whole plant extract of Synedrella nodiflora (L.) Gaertn (Asteraceae). J Pharm Bioall Sci. 2012;4:140\u20138.","journal-title":"J Pharm Bioall Sci"},{"key":"1901_CR14","first-page":"54","volume":"2","author":"E Woode","year":"2011","unstructured":"Woode E, Amoateng P, Abotsi WMK. Ethopharmacological analysis of the effects of the whole plant extract of Synedrella nodiflora (L.) Gaertn (Asteraceae) in murine models. Der Pharmacia Sinica. 2011;2:54\u201367.","journal-title":"Der Pharmacia Sinica"},{"key":"1901_CR15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5530\/ax.2011.3.10","volume":"1","author":"P Amoateng","year":"2011","unstructured":"Amoateng P, Assumeng Koffuor G, Sarpong K, Oteng AK. Free Radical Scavenging and Anti-lipid Peroxidative Effects of a Hydro-ethanolic Extract of the Whole Plant of Synedrella nodiflora (L.) Gaertn (Asteraceae). Free Rad Antiox. 2011;1:70\u20138.","journal-title":"Free Rad Antiox"},{"key":"1901_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/jbcpp-2014-0084","volume":"26","author":"P Amoateng","year":"2015","unstructured":"Amoateng P, Adjei S, Osei-Safo D, Ameyaw EO, Ahedor B, N'Guessan BB, Nyarko AK. A hydro-ethanolic extract of Synedrella nodiflora (L.) Gaertn ameliorates hyperalgesia and allodynia in vincristine-induced neuropathic pain in rats. J Basic Clin Physiol Pharmacol. 2015;26:383\u201394.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"1901_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3923\/jpt.2009.17.29","volume":"4","author":"E Woode","year":"2009","unstructured":"Woode E, Amoateng P, Ansah C, Duwiejua M. Anti-Nociceptive Effects of an Ethanolic Extract of the Whole Plant of Synedrella nodiflora (L.) Gaertn in Mice: Involvement of Adenosinergic Mechanisms. J Pharmacol Toxicol. 2009;4:17\u201329.","journal-title":"J Pharmacol Toxicol"},{"key":"1901_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4314\/jmbs.v3i1.5","volume":"3","author":"S Adjei","year":"2014","unstructured":"Adjei S, Amoateng P, Osei-Safo D, Ahedor B, N\u2019guessan BB, Addo P, Asiedu-Gyekye IJ. Biochemical and haematological changes following an acute toxicity study of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L) Gaertn in male Sprague-Dawley rats. J Med Biomed Sci. 2014;3:31\u20137.","journal-title":"J Med Biomed Sci"},{"key":"1901_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/0973-8258.142695","volume":"8","author":"S Adjei","year":"2014","unstructured":"Adjei S, Amoateng P, Osei-Safo D, Sasu C, N\u2019guessan BB, Addo P, Asiedu-Gyekye IJ. Sub-acute toxicity of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L) Gaertn in rats. Int J Green Pharm. 2014;8:271\u20135.","journal-title":"Int J Green Pharm"},{"key":"1901_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4314\/gmj.v50i3.8","volume":"50","author":"P Amoateng","year":"2016","unstructured":"Amoateng P, Adjei S, Osei-Safo D, Ahedor B, Mahmood SA, N\u2019guessan BB, Asiedu-Gyekye IJ, Nyarko AK. Long-term continuous administration of a hydro-ethanolic extract of Synedrella nodiflora (L) Gaertn in male Sprague-Dawley rats: biochemical, haematological and histopathological changes. Ghana Med J. 2016;50:163\u201371.","journal-title":"Ghana Med J"},{"key":"1901_CR21","unstructured":"Amoateng P. Neuropharmacological effects of Synedrella nodiflora:Anticonvulsant and related effects of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L.) Gaertn: LAP Lambert Academic Publishing; Saarbr\u00fccken, Germany,\u00a02011. p. 120\u20131."},{"key":"1901_CR22","doi-asserted-by":"crossref","unstructured":"Amoateng P, Adjei S, Osei-Safo D, Kukuia KKE, Kretchy IA, Sarkodie JA, N\u2019Guessan BB: Analgesic effects of a hydro-ethanolic whole plant extract of Synedrella nodiflora (L.) Gaertn in paclitaxel-induced neuropathic pain in rats. BMC Res Notes. 2017;10:226.","DOI":"10.1186\/s13104-017-2551-7"},{"key":"1901_CR23","volume-title":"Trease and Evans' Pharmacognosy","author":"WC Evans","year":"2002","unstructured":"Evans WC. Trease and Evans' Pharmacognosy. 15th ed. Saunders Ltd: Edinburgh; 2002.","edition":"15"},{"key":"1901_CR24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00401402","volume":"13","author":"S Irwin","year":"1968","unstructured":"Irwin S. Comprehensive observational assessment. Asystematic,quantitative procedure for assessing the behavioural and physiologic state of the mouse. Psychoparmacologia. 1968;13:222\u201356.","journal-title":"Psychoparmacologia"},{"key":"1901_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(84)91241-1","volume":"293","author":"SK Kenneth","year":"1984","unstructured":"Kenneth SK, Kenneth ID. Genetic control of apomorphine induced climbing behaviour in two inbred mouse strains. Brain Res. 1984;293:343\u201351.","journal-title":"Brain Res"},{"key":"1901_CR26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jep.2004.10.003","volume":"97","author":"S Amos","year":"2005","unstructured":"Amos S, Abbah J, Chindo B, Edmond I, Binda L, Adzu B, Buhari S, Odutola AA, Wambebe C, Gamaniel K. Neuropharmacological effects of the aqueous extract of Nauclea latifolia root bark in rats and mice. J Ethnopharmacol. 2005;97:53\u20137.","journal-title":"J Ethnopharmacol"},{"key":"1901_CR27","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1128\/AAC.48.11.4097-4102.2004","volume":"48","author":"Q Fivelman","year":"2004","unstructured":"Fivelman Q, Adagu I, Warhurst D. Modified fixed-ratio isobologram method for in vitro interaction between atovaquone and proguanil or dihydroartemisinin against drug resistant strain of Plasmodium falciparum. Antimicrob Agents Chemother. 2004;48:4097\u2013102.","journal-title":"Antimicrob Agents Chemother"},{"key":"1901_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.1986.tb10164.x","volume":"87","author":"AS Davis","year":"1986","unstructured":"Davis AS, Jenner P, Marsden CD. A comparison of motor behaviours in groups of rats distinguished by their climbing response to apomorphine. Br J Pharmacol. 1986;87:129\u201337.","journal-title":"Br J Pharmacol"},{"key":"1901_CR29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","volume":"102","author":"PR Sanberg","year":"1988","unstructured":"Sanberg PR, Bunsey MD, Giordano M, Norman AB. The catalepsy test: its ups and downs. Behav Neurosci. 1988;102:748.","journal-title":"Behav Neurosci"},{"key":"1901_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jep.2012.06.026","volume":"143","author":"GS Ta\u00efwe","year":"2012","unstructured":"Ta\u00efwe GS, Bum EN, Talla E, Dawe A, Moto FCO, Ngoupaye GT, Sidiki N, Dabole B, Dzeufiet PDD, Dimo T. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents. J Ethnopharmacol. 2012;143:213\u201320.","journal-title":"J Ethnopharmacol"},{"key":"1901_CR31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0253-7613.32526","volume":"39","author":"S Pemminati","year":"2007","unstructured":"Pemminati S, Nair V, Dorababu P, Gopalakrishna H, Pai M. Effect of ethanolic leaf extract of Ocimum sanctum on haloperidol-induced catalepsy in albino mice. Indian J Pharmacol. 2007;39:87.","journal-title":"Indian J Pharmacol"},{"key":"1901_CR32","first-page":"18","volume-title":"Drug discovery and evaluation: safety and pharmacokinetic assays","author":"RD Porsolt","year":"2006","unstructured":"Porsolt RD, Castagn\u00e9 V, D\u00fcrm\u00fcller N, Lemaire M, Moser P, Roux S, France CP. Central Nervous System (CNS) Safety Pharmacology Studies. In: Vogel HG, editor. Drug discovery and evaluation: safety and pharmacokinetic assays. Germany: Springer-Verlag; 2006. p. 18."},{"key":"1901_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(89)90178-7","volume":"161","author":"J Arnt","year":"1989","unstructured":"Arnt J, Hyttel J. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT 2 agonist DOI. Eur J Pharmacol. 1989;161:45\u201351.","journal-title":"Eur J Pharmacol"},{"key":"1901_CR34","first-page":"158","volume-title":"Rang & Dale\u2019s Pharmacology","author":"R Rang","year":"2012","unstructured":"Rang R, Dale M, Ritter J, Flower R, Henderson G. Chapter 13: Cholinergic transmission. In: Rang & Dale\u2019s Pharmacology. 7th ed. Edinburgh: Elsevier Churchill Livingstone; 2012. p. 158.","edition":"7"},{"key":"1901_CR35","unstructured":"Trevor A, Way W. Sedative-Hypnotics. In: Basic and Clinical Pharmacology. Katzung B, Masters S, Trevor A, 12. USA: McGraw-Hill Lange; 2012: 373-386."},{"key":"1901_CR36","first-page":"2","volume-title":"The RBI Handbook of Receptor Clarification and signal Transduction","author":"KJ Walting","year":"1998","unstructured":"Walting KJ. Overview of central nervous system receptors. In: Walting KJ, editor. The RBI Handbook of Receptor Clarification and signal Transduction. MA: RBI, Natick; 1998. p. 2\u201345."},{"key":"1901_CR37","first-page":"287","volume":"4","author":"L Nesa","year":"2014","unstructured":"Nesa L, Munira S, Mollika S, Islam M, Choin H, Chouduri AU, Naher N. Evaluation of analgesic, anti-inflammatory and CNS depressant activities of methanolic extract of Lawsonia inermis barks in mice. Avicenna J Phytomed. 2014;4:287\u201396.","journal-title":"Avicenna J Phytomed"},{"key":"1901_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12906-015-0635-2","volume":"15","author":"A Zaman","year":"2015","unstructured":"Zaman A, Khan MSS, Akter L, Syeed SH, Akter J, Al Mamun A, Alam ME, Habib MA, Jalil MA. Exploring new pharmacology and toxicological screening and safety evaluation of one widely used formulation of Nidrakar Bati from South Asia region. BMC Complement Altern Med. 2015;15:121.","journal-title":"BMC Complement Altern Med"},{"key":"1901_CR39","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1590\/1516-4446-2013-1164","volume":"35","author":"PH Gobira","year":"2013","unstructured":"Gobira PH, Ropke J, Aguiar DC, Crippa JAS, Moreira FA. Animal models for predicting the efficacy and side effects of antipsychotic drugs. Rev Bras Psiquiatr. 2013;35:S132\u20139.","journal-title":"Rev Bras Psiquiatr"},{"key":"1901_CR40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","volume":"164","author":"CA Jones","year":"2011","unstructured":"Jones CA, Watson DJG, Fone KCF. Animal models of schizophrenia. Br J Pharmacol. 2011;164:1162\u201394.","journal-title":"Br J Pharmacol"},{"key":"1901_CR41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","volume":"23","author":"BK Lipska","year":"2000","unstructured":"Lipska BK, Weinberger DR. To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test. Neuropsychopharmacology. 2000;23:223\u201339.","journal-title":"Neuropsychopharmacology"},{"key":"1901_CR42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<235::AID-DDR7>3.0.CO;2-R","volume":"50","author":"I Weiner","year":"2000","unstructured":"Weiner I, Gaisler I, Schiller D, Green A, Zuckerman L, Joel D. Screening of antipsychotic drugs in animal models. Drug Dev Res. 2000;50:235\u201349.","journal-title":"Drug Dev Res"},{"key":"1901_CR43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0091-3057(91)90150-Z","volume":"39","author":"K Matsumoto","year":"1991","unstructured":"Matsumoto K, Cai B, Ohta H, Imamura L, Watanabe H. Apparent enhancement by SCH 23390 of apomorphine-induced locomotor activity in mice. Pharmacol Biochem Behav. 1991;39:699\u2013703.","journal-title":"Pharmacol Biochem Behav"},{"key":"1901_CR44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s002130051086","volume":"146","author":"JJ Battisti","year":"1999","unstructured":"Battisti JJ, Uretsky NJ, Wallace LJ. Sensitization of apomorphine-induced stereotyped behavior in mice is context dependent. Psychopharmacology. 1999;146:42\u20138.","journal-title":"Psychopharmacology"},{"key":"1901_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0160-5402(90)90022-D","volume":"24","author":"K Matsumoto","year":"1990","unstructured":"Matsumoto K, Bing C, Sasaki K, Watanabe H. Methamphetamine-and apomorphine-induced changes in spontaneous motor activity using a new system to detect and analyze motor activity in mice. J Pharmacol Methods. 1990;24:111\u20139.","journal-title":"J Pharmacol Methods"},{"key":"1901_CR46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/BF00431856","volume":"56","author":"H Marcais","year":"1978","unstructured":"Marcais H, Protais P, Costentin J, Schwartz J. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice. Psychopharmacology. 1978;56:233\u20134.","journal-title":"Psychopharmacology"},{"key":"1901_CR47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(80)90411-6","volume":"12","author":"RE Wilcox","year":"1980","unstructured":"Wilcox RE, Smith RV, Anderson JA, Riffee WH. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity. Pharmacol Biochem Behav. 1980;12:29\u201333.","journal-title":"Pharmacol Biochem Behav"},{"key":"1901_CR48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0014-2999(86)90391-2","volume":"121","author":"H Szechtman","year":"1986","unstructured":"Szechtman H. Behavior performed at onset of drug action and apomorphine stereotypy. Eur J Pharmacol. 1986;121:49\u201356.","journal-title":"Eur J Pharmacol"},{"key":"1901_CR49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0028-3908(70)90074-2","volume":"9","author":"JM Stolk","year":"1970","unstructured":"Stolk JM, Rech RH. Antagonism of O-amphetamine by methylp-tyrosin. Behavioural evidence for participation of cathelcolamine stores and synthesis in the amphetamine stimulant response. Neuropharmacology. 1970;9:249\u201363.","journal-title":"Neuropharmacology"},{"key":"1901_CR50","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/archpsyc.1979.01780060047005","volume":"36","author":"B Shopsin","year":"1979","unstructured":"Shopsin B, Klein H, Aaronsom M, Collora M. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison. Arch Gen Psych. 1979;36:657\u201364.","journal-title":"Arch Gen Psych"},{"key":"1901_CR51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00428402","volume":"85","author":"W Klemm","year":"1985","unstructured":"Klemm W. Evidence for a cholinergic role in haloperidol-induced catalepsy. Psychopharmacology. 1985;85:139\u201342.","journal-title":"Psychopharmacology"},{"key":"1901_CR52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)38100-0","volume":"265","author":"BS Neal-Beliveau","year":"1993","unstructured":"Neal-Beliveau BS, Joyce JN, Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther. 1993;265:207\u201317.","journal-title":"J Pharmacol Exp Ther"},{"key":"1901_CR53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 2007;30:228\u201335.","journal-title":"Trends Neurosci"},{"key":"1901_CR54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0149-7634(95)00057-7","volume":"20","author":"M-L Wadenberg","year":"1996","unstructured":"Wadenberg M-L. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev. 1996;20:325\u201339.","journal-title":"Neurosci Biobehav Rev"},{"key":"1901_CR55","doi-asserted-by":"crossref","unstructured":"Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S. Risperidone versus other atypical antipsychotics for schizophrenia. Cochrane Database Sys Rev. 2011:CD006626.","DOI":"10.1002\/14651858.CD006626.pub2"},{"key":"1901_CR56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MJT.0b013e318230ae52","volume":"21","author":"SK Praharaj","year":"2014","unstructured":"Praharaj SK, Jana AK, Sarkhel S, Sinha VK. Acute dystonia, akathisia, and parkinsonism induced by ziprasidone. Am J Ther. 2014;21:38\u201340.","journal-title":"Am J Ther"},{"key":"1901_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/JCP.0b013e3182856826","volume":"33","author":"MH Chen","year":"2013","unstructured":"Chen MH, Liou YJ. Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder. J Clin Psychopharmacol. 2013;33:269\u201370.","journal-title":"J Clin Psychopharmacol"},{"key":"1901_CR58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/JCP.0000000000000305","volume":"35","author":"RA Zoccali","year":"2015","unstructured":"Zoccali RA, Bruno A, Muscatello MR. Efficacy and safety of sertindole in schizophrenia: a clinical review. J Clin Psychopharmacol. 2015;35:286\u201395.","journal-title":"J Clin Psychopharmacol"},{"key":"1901_CR59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0019-5545.130510","volume":"56","author":"N Mandal","year":"2014","unstructured":"Mandal N, Singh OP, Sen S. Extrapyramidal side effects with low doses of amisulpride. Indian J Psych. 2014;56:197\u20139.","journal-title":"Indian J Psych"},{"key":"1901_CR60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","volume":"38","author":"C Rummel-Kluge","year":"2012","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W, Davis JM, Leucht S. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull. 2012;38:167\u201377.","journal-title":"Schizophr Bull"},{"key":"1901_CR61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373:31\u201341.","journal-title":"Lancet"},{"key":"1901_CR62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"1901_CR63","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd2806","volume":"8","author":"G Grunder","year":"2009","unstructured":"Grunder G, Hippius H, Carlsson A. The 'atypicality' of antipsychotics: a concept re-examined and re-defined. Nature Rev Drug Discov. 2009;8:197\u2013202.","journal-title":"Nature Rev Drug Discov"},{"key":"1901_CR64","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2165\/0023210-200822120-00007","volume":"22","author":"RD Jindal","year":"2008","unstructured":"Jindal RD, Keshavan MS. Classifying antipsychotic agents : need for new terminology. CNS Drugs. 2008;22:1047\u201359.","journal-title":"CNS Drugs"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-017-1901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:50:28Z","timestamp":1750798228000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-017-1901-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1186\/s12906-017-1901-2","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]},"article-number":"389"}}